These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 1991829)

  • 41. Corrigendum to "Effect of crocetin on vascular smooth muscle cells migration induced by advanced glycosylation end products" [Microvasc. Res. 112 (2017) 30-36/ MVR_2016_83].
    Xiang M; Yang R; Zhang Y; Wu P; Wang L; Gao Z; Wang J
    Microvasc Res; 2024 May; 153():104670. PubMed ID: 38388326
    [No Abstract]   [Full Text] [Related]  

  • 42. Modulators of Nitric Oxide-Dependent Osteoinductive Activity of Human Red Blood Cells.
    Pavlaki M; Moiko K; Thomaidis A; Chalikias G; Schäfer K; Konstantinides S; Tziakas D
    TH Open; 2022 Jul; 6(3):e248-e250. PubMed ID: 36299806
    [No Abstract]   [Full Text] [Related]  

  • 43. The RAGE Axis: A Relevant Inflammatory Hub in Human Diseases.
    Rojas A; Lindner C; Schneider I; Gonzalez I; Uribarri J
    Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672429
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of Age on Endothelial Function of Saphenous Vein Grafts in Coronary Artery Bypass Grafting.
    Saemann L; Wernstedt L; Pohl S; Stiller M; Willsch J; Hofmann B; Veres G; Simm A; Szabó G
    J Clin Med; 2023 Aug; 12(17):. PubMed ID: 37685521
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vascular nitric oxide resistance in type 2 diabetes.
    Bahadoran Z; Mirmiran P; Kashfi K; Ghasemi A
    Cell Death Dis; 2023 Jul; 14(7):410. PubMed ID: 37433795
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diabetic Nephropathy and Gaseous Modulators.
    Juin SK; Ouseph R; Gondim DD; Jala VR; Sen U
    Antioxidants (Basel); 2023 May; 12(5):. PubMed ID: 37237955
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RAGE signaling regulates the progression of diabetic complications.
    Taguchi K; Fukami K
    Front Pharmacol; 2023; 14():1128872. PubMed ID: 37007029
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel Biotherapeutics Targeting Biomolecular and Cellular Approaches in Diabetic Wound Healing.
    Singh SK; Dwivedi SD; Yadav K; Shah K; Chauhan NS; Pradhan M; Singh MR; Singh D
    Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831151
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association between Advanced Glycation End-Products, Carotenoids, and Severe Erectile Dysfunction.
    Fujita N; Ishida M; Iwane T; Suganuma H; Matsumoto M; Hatakeyama S; Yoneyama T; Hashimoto Y; Mikami T; Itoh K; Ohyama C
    World J Mens Health; 2023 Jul; 41(3):701-711. PubMed ID: 36649922
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of Nitric Oxide-Derived Metabolites in Reactions of Methylglyoxal with Lysine and Lysine-Rich Protein Leghemoglobin.
    Shumaev KB; Kosmachevskaya OV; Nasybullina EI; Ruuge EK; Topunov AF
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613614
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Involvement of AGE and Its Receptors in the Pathogenesis of Hypertension in Elderly People and Its Treatment.
    Prasad K
    Int J Angiol; 2022 Dec; 31(4):213-221. PubMed ID: 36588874
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Receptor for Advanced Glycation End Product, Organ Crosstalk, and Pathomechanism Targets for Comprehensive Molecular Therapeutics in Diabetic Ischemic Stroke.
    Rao NL; Kotian GB; Shetty JK; Shelley BP; Dmello MK; Lobo EC; Shankar SP; Almeida SD; Shah SR
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421725
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterisation of key biomarkers in diabetic ulcers via systems bioinformatics.
    Zhang Z; Zhang Y; Yang D; Luo Y; Luo Y; Ru Y; Song J; Fei X; Chen Y; Li B; Jiang J; Kuai L
    Int Wound J; 2023 Feb; 20(2):529-542. PubMed ID: 36181454
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options.
    Salvatore T; Galiero R; Caturano A; Vetrano E; Loffredo G; Rinaldi L; Catalini C; Gjeloshi K; Albanese G; Di Martino A; Docimo G; Sardu C; Marfella R; Sasso FC
    Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140374
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathogenesis of Distal Symmetrical Polyneuropathy in Diabetes.
    Smith S; Normahani P; Lane T; Hohenschurz-Schmidt D; Oliver N; Davies AH
    Life (Basel); 2022 Jul; 12(7):. PubMed ID: 35888162
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endothelial Dysfunction and Platelet Hyperactivation in Diabetic Complications Induced by Glycemic Variability.
    Huang Y; Yue L; Qiu J; Gao M; Liu S; Wang J
    Horm Metab Res; 2022 Jul; 54(7):419-428. PubMed ID: 35835141
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum Adiponectin and Nitric Oxide Levels in Type II Diabetes and Its Correlation With Lipid Profile.
    Tuppad S; Medala K; Umesh M; Gaur A; Ganji V; Sakthivadivel V; Kumar P
    Cureus; 2022 Apr; 14(4):e24613. PubMed ID: 35664415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endothelial Dysfunction and Diabetic Cardiomyopathy.
    Wang M; Li Y; Li S; Lv J
    Front Endocrinol (Lausanne); 2022; 13():851941. PubMed ID: 35464057
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Advanced Glycation End-Products (AGEs): Formation, Chemistry, Classification, Receptors, and Diseases Related to AGEs.
    Twarda-Clapa A; Olczak A; Białkowska AM; Koziołkiewicz M
    Cells; 2022 Apr; 11(8):. PubMed ID: 35455991
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Revisiting Methodologies for In Vitro Preparations of Advanced Glycation End Products.
    Sahi AK; Verma P; Varshney N; Gundu S; Mahto SK
    Appl Biochem Biotechnol; 2022 Jun; 194(6):2831-2855. PubMed ID: 35257316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.